$23.19
-1.0%Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
Strong gross margins indicate healthy pricing and efficient production or service delivery.
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
AZTA โข NASDAQ
| Azenta, Inc. Income Statement | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | Sep 2008 | Sep 2007 | Sep 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
593.8M | 573.4M | 665.1M | 555.5M | 513.7M | 897.3M | 781.9M | 631.6M | 692.9M | 560.3M | 552.7M | 482.8M | 451M | 519.5M | 688.1M | 593M | 218.7M | 526.4M | 743.3M | 692.9M | |
GROSS PROFIT | ||||||||||||||||||||
(323.5M) | (318.8M) | (431.8M) | (324.9M) | (299.2M) | (517.2M) | (465.1M) | (385.5M) | (425.5M) | (362.2M) | (363.6M) | (315.5M) | (305M) | (346M) | (465.1M) | (426.7M) | (224.7M) | (399.5M) | (523.7M) | (448.1M) | |
270.3M | 254.6M | 233.3M | 230.6M | 214.5M | 380M | 316.8M | 246.1M | 267.4M | 198.1M | 189.1M | 167.3M | 146M | 173.5M | 223M | 166.3M | -6M | 126.8M | 219.6M | 244.8M | |
OPERATING INCOME | ||||||||||||||||||||
(281.5M) | (284.6M) | (315.5M) | (254.6M) | (210.9M) | (300.2M) | (268.3M) | (214M) | (200.1M) | (181.8M) | (167.5M) | (163.7M) | (148.5M) | (157.6M) | (142.4M) | (116.8M) | (122.8M) | (357M) | (172.1M) | (211.7M) | |
(251.2M) | (253.1M) | (281.5M) | (227.1M) | (188.5M) | (241.1M) | (212M) | (167M) | (153.1M) | (130.3M) | (115.3M) | (111.1M) | (99.5M) | (110.2M) | (102.5M) | (85.6M) | (91.2M) | (110.5M) | (120.4M) | (141M) | |
(30.4M) | (31.5M) | (34M) | (27.5M) | (22.4M) | (59.1M) | (56.4M) | (46.9M) | (47M) | (51.5M) | (52.2M) | (52.6M) | (49M) | (47.5M) | (39.8M) | (31.2M) | (31.6M) | (42.9M) | (51.7M) | (70.7M) | |
-11.3M | -30M | -82.2M | -24M | 3.6M | 78.5M | 46.5M | 31.4M | 64.1M | 4.2M | 16.9M | -2.7M | -9M | 9.6M | 79.6M | 47M | -228M | -237.5M | 40.4M | 27.8M | |
PRE-TAX INCOME | ||||||||||||||||||||
(0.0) | (0.0) | (0.0) | (4.6M) | (2M) | (2.9M) | (22.3M) | (9.5M) | (408K) | (157K) | (395K) | (202K) | (2K) | (14K) | (65K) | (80K) | (454K) | (407K) | (583K) | (9.4M) | |
18.8M | 33.2M | 43.7M | 15.7M | -1.4M | -2.1M | -20.8M | -7.6M | 56K | 295K | 504K | 748K | 1M | 1.2M | 1.1M | 1M | 2.3M | 7M | 11.3M | 4.3M | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -1.4M | -1.5M | (0.0) | -645K | -579K | (421K) | (256K) | (1.2M) | (0.0) | (1M) | (0.0) | (0.0) | (203.6M) | (0.0) | (0.0) | |
4.1M | 10.9M | 51.8M | 14.1M | -52.6M | -5.2M | 48.7M | -10.9M | 46.7M | -284K | 925K | 1M | -9.1M | 1.9M | 48M | 9.1M | 1.1M | 1.3M | 15.3M | -3.7M | |
-7.1M | -19.1M | -30.4M | -9.9M | -49M | 75M | 9.9M | 20.5M | 65.4M | 4M | 17.8M | -1.7M | -6.8M | 11.4M | 127.6M | 56.1M | -226.9M | -236.2M | 55.6M | 29.9M | |
NET INCOME | ||||||||||||||||||||
-31.6M | (5.2M) | -17.6M | (1.4M) | -20.1M | (9.9M) | (50K) | -47.3M | (12.1M) | (75.8M) | (3.4M) | -2M | -2.2M | -123.3M | (2M) | -2.7M | (643K) | (1.2M) | (2.3M) | (4.7M) | |
-55.8M | -164.9M | -14.3M | -429M | 110.7M | 64.9M | 9.9M | 116.6M | 62.6M | -69.5M | 14.2M | 31.4M | -2.2M | 136.8M | 128.4M | 59M | -227.9M | -235.9M | 151.5M | 25.9M |
AZTA - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 08, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 07, 2026 | April 06, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 02, 2026 | March 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 04, 2026 | March 04, 2026 | 2026 | |
10-Q 10-Q 2025 Q4 Q4 | February 05, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 04, 2026 | February 04, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 02, 2026 | January 29, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 29, 2026 | January 28, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 29, 2025 | December 23, 2025 | 2025 |
Continue your AZTA research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.